The High Cost of Insulin: Bridging Gaps on the Path to Affordable Care
Cardiometabolic Health Congress
JANUARY 19, 2024
This recent announcement by Sanofi to lower insulin costs is a step to ensure every American has access to this life-saving medication. With drug costs historically high and subject to inflation, there is an urgent need to develop and approve insulin alternatives that are effective and affordable for all.
59 
Let's personalize your content